U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel), a New CAR T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma View more
Central Logic Saw Record-Breaking Growth, Awareness and Momentum in 2020 as Health Systems Increase Focus on ‘Operating as One’ View more
GE Healthcare Named “2020 Global Company of the Year” by Frost & Sullivan for its AI-based Command Centers that Help Hospitals Make Real-time Decisions That Improve Care Delivery View more
